|
Cardiovascular Pharmacology
Citations 211-220 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Corrections
Correction
-
Circulation 2007;115:e536, doi:10.1161/CIRCULATIONAHA.107.184237
[Full text]
- Molecular Cardiology
Poly(ADP-Ribose) Polymerase Inhibition Reduces Atherosclerotic Plaque Size and Promotes Factors of Plaque Stability in Apolipoprotein E–Deficient Mice: Effects on Macrophage Recruitment, Nuclear Factor- B Nuclear Translocation, and Foam Cell Death
- Karine Oumouna-Benachour, Chetan P. Hans, Yasuhiro Suzuki, Amarjit Naura, Rahul Datta, Souad Belmadani, Kenneth Fallon, Cooper Woods, and A. Hamid Boulares
Circulation 2007;115:2442-2450; published online before print as doi:10.1161/CIRCULATIONAHA.106.668756
[Abstract]
[Full text]
- Molecular Cardiology
Compartmentalization of Cardiac ß-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5
- Eiki Takimoto, Diego Belardi, Carlo G. Tocchetti, Susan Vahebi, Gianfrancesco Cormaci, Elizabeth A. Ketner, An L. Moens, Hunter C. Champion, and David A. Kass
Circulation 2007;115:2159-2167; published online before print as doi:10.1161/CIRCULATIONAHA.106.643536
[Abstract]
[Full text]
- Contemporary Reviews in Cardiovascular Medicine
Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
- Andrew O. Maree and Desmond J. Fitzgerald
Circulation 2007;115:2196-2207, doi:10.1161/CIRCULATIONAHA.106.675991
[Full text]
- Corrections
Correction
-
Circulation 2007;115:e408, doi:10.1161/CIRCULATIONAHA.107.183163
[Full text]
- Articles
Poly(ADP-Ribose) Polymerase Inhibition Reduces Atherosclerotic Plaque Size and Promotes Factors of Plaque Stability in Apolipoprotein E-Deficient Mice. Effects on Macrophage Recruitment, Nuclear Factor-B Nuclear Translocation, and Foam Cell Death
- Karine Oumouna-Benachour, Chetan P. Hans, Yasuhiro Suzuki, Amarjit Naura, Rahul Datta, Souad Belmadani, Kenneth Fallon, Cooper Woods, and A. Hamid Boulares
Circulation published April 16, 2007, doi:10.1161/CIRCULATIONAHA.106.668756
[Abstract]
- Articles
Compartmentalization of Cardiac  -Adrenergic Inotropy Modulation by Phosphodiesterase Type 5
- Eiki Takimoto, Diego Belardi, Carlo G. Tocchetti, Susan Vahebi, Gianfrancesco Cormaci, Elizabeth A. Ketner, An L. Moens, Hunter C. Champion, and David A. Kass
Circulation published April 9, 2007, doi:10.1161/CIRCULATIONAHA.106.643536
[Abstract]
- AHA Scientific Statements
Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians: A Scientific Statement From the American Heart Association
- Elliott M. Antman, Joel S. Bennett, Alan Daugherty, Curt Furberg, Harold Roberts, and Kathryn A. Taubert
Circulation 2007;115:1634-1642; published online before print as doi:10.1161/CIRCULATIONAHA.106.181424
[Full text]
- Heart Failure
Direct Myocardial Effects of Levosimendan in Humans With Left Ventricular Dysfunction: Alteration of Force-Frequency and Relaxation-Frequency Relationships
- Michael M. Givertz, Costa Andreou, Chester H. Conrad, and Wilson S. Colucci
Circulation 2007;115:1218-1224; published online before print as doi:10.1161/CIRCULATIONAHA.106.668640
[Abstract]
[Full text]
- Articles
Direct Myocardial Effects of Levosimendan in Humans With Left Ventricular Dysfunction. Alteration of Force-Frequency and Relaxation-Frequency Relationships
- Michael M. Givertz, Costa Andreou, Chester H. Conrad, and Wilson S. Colucci
Circulation published March 5, 2007, doi:10.1161/CIRCULATIONAHA.106.668640
[Abstract]
|
|
